Retinoblastoma (RB) is a rare form of cancer. It affects light-sensitive retinal cells that help our eyes to see. It is the most common eye (ocular) malignancy in children and the third most common cancer in children. From 250 to 350 new cases are diagnosed each year in America. Approximately 90 percent occur in children under five years of age.
There are two types of retinoblastoma; one hereditary and affecting both eyes (10 percent of cases) and the other type non-hereditary, affecting only one eye. In all cases, genetic counseling is important for children with a germ-line mutation. This disease is so rare that it is critical to have your child treated at an institution that specializes in retinoblastoma, such as Sylvester Comprehensive Center.
Why Choose Sylvester Comprehensive Cancer Center?
Sylvester is an NCI-designated cancer center. The National Cancer Institute has recognized Sylvester for its outstanding work conducting research in its laboratories, treating patients in its clinics and hospitals, and reaching out to medically underserved communities with innovative prevention strategies.
Localized treatment. Sylvester in the only center in the Southeastern U.S. and one of only four or five in the country that is highly skilled at a treatment called intra-arterial chemotherapy, that provides more localized treatment, sparing the child from systemic treatment and greatly reducing the need to remove the eye.
Personalized recommendations. Whether you have a familial predisposition to particular cancers, or you want your child to stay healthy long-term, we keep your goals in mind when developing your screening and treatment schedules.
Bascom Palmer Eye Institute ranked #1 by U.S. News & World Report. Bascom Palmer Eye Institute is the top-rated facility in the country for the treatment of diseases and disorders of the eye, according to U.S. News & World Report. When you choose us for your eye care, you will receive the best care in the nation in a compassionate setting.